These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27405679)

  • 1. State of the art: gene therapy of haemophilia.
    Spencer HT; Riley BE; Doering CB
    Haemophilia; 2016 Jul; 22 Suppl 5():66-71. PubMed ID: 27405679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia Gene Therapy: Ready for Prime Time?
    VandenDriessche T; Chuah MK
    Hum Gene Ther; 2017 Nov; 28(11):1013-1023. PubMed ID: 28793786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
    Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
    Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilia gene therapy: From trailblazer to gamechanger.
    Evens H; Chuah MK; VandenDriessche T
    Haemophilia; 2018 May; 24 Suppl 6():50-59. PubMed ID: 29878653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immune Response to the fVIII Gene Therapy in Preclinical Models.
    Patel SR; Lundgren TS; Spencer HT; Doering CB
    Front Immunol; 2020; 11():494. PubMed ID: 32351497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection.
    Nambiar B; Cornell Sookdeo C; Berthelette P; Jackson R; Piraino S; Burnham B; Nass S; Souza D; O'Riordan CR; Vincent KA; Cheng SH; Armentano D; Kyostio-Moore S
    Hum Gene Ther Methods; 2017 Feb; 28(1):23-38. PubMed ID: 28166648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for the hemophilias.
    VandenDriessche T; Collen D; Chuah MK
    J Thromb Haemost; 2003 Jul; 1(7):1550-8. PubMed ID: 12871290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.
    Couto LB
    Semin Thromb Hemost; 2004 Apr; 30(2):161-71. PubMed ID: 15118928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of haemophilia gene therapy.
    High KH; Nathwani A; Spencer T; Lillicrap D
    Haemophilia; 2014 May; 20 Suppl 4():43-9. PubMed ID: 24762274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus-mediated gene transfer for the haemophilias.
    Walsh CE; Chao H
    Haemophilia; 2002 Mar; 8 Suppl 2():60-7. PubMed ID: 11966856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemophilia Healing with AAV: Navigating the Frontier of Gene Therapy.
    Khan SU; Khan MU; Suleman M; Inam A; Din MAU
    Curr Gene Ther; 2024; 24(4):265-277. PubMed ID: 38284735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WFH State-of-the-art paper 2020: In vivo lentiviral vector gene therapy for haemophilia.
    Cantore A; Naldini L
    Haemophilia; 2021 Feb; 27 Suppl 3(Suppl 3):122-125. PubMed ID: 32537776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging gene therapies for haemophilia A and B.
    Kaczmarek R; Miesbach W; Ozelo MC; Chowdary P
    Haemophilia; 2024 Apr; 30 Suppl 3():12-20. PubMed ID: 38528615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What´s new in Gene Therapy of Hemophilia.
    Rodriguez-Merchan EC
    Curr Gene Ther; 2018; 18(2):107-114. PubMed ID: 29446741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice.
    Ramezani A; Zweier-Renn LA; Hawley RG
    Thromb Haemost; 2011 Apr; 105(4):676-87. PubMed ID: 21264447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophilia.
    Peyvandi F; Garagiola I
    Haemophilia; 2019 Sep; 25(5):738-746. PubMed ID: 31282050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in gene therapy for hemophilia.
    Chuah MK; Nair N; VandenDriessche T
    Hum Gene Ther; 2012 Jun; 23(6):557-65. PubMed ID: 22671033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an optimized lentiviral vector encoding a high-expression factor VIII transgene for gene therapy of hemophilia A.
    Johnston JM; Denning G; Doering CB; Spencer HT
    Gene Ther; 2013 Jun; 20(6):607-15. PubMed ID: 22996197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete correction of hemophilia A with adeno-associated viral vectors containing a full-size expression cassette.
    Lu H; Chen L; Wang J; Huack B; Sarkar R; Zhou S; Xu R; Ding Q; Wang X; Wang H; Xiao W
    Hum Gene Ther; 2008 Jun; 19(6):648-54. PubMed ID: 18500941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microRNA-regulated and GP64-pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Hemophilia A.
    Matsui H; Hegadorn C; Ozelo M; Burnett E; Tuttle A; Labelle A; McCray PB; Naldini L; Brown B; Hough C; Lillicrap D
    Mol Ther; 2011 Apr; 19(4):723-30. PubMed ID: 21285959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.